Vascular galectins: regulators of tumor progression and targets for cancer therapy.
about
Galectin-Binding O-Glycosylations as Regulators of MalignancyThe Role of Galectin-1 in Cancer Progression, and Synthetic Multivalent Systems for the Study of Galectin-1The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future.Galectin expression profiling identifies galectin-1 and Galectin-9Δ5 as prognostic factors in stage I/II non-small cell lung cancer.Comparison of galectin expression signatures in rejected and accepted murine corneal allografts.Galectin-1, -3 and -9 Expression and Clinical Significance in Squamous Cervical CancerChemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis.Structural basis of redox-dependent modulation of galectin-1 dynamics and function.Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma.Galectin-1 and -9 in angiogenesis: a sweet couple.Glycobiology of platelet-endothelial cell interactions.Galectin-8: a matricellular lectin with key roles in angiogenesis.Galectins as therapeutic targets for hematological malignancies: a hopeful sweetness.Galectins in tumor angiogenesisDifferential Spatiotemporal Patterns of Galectin Expression are a Hallmark of Endotheliochorial Placentation.Dual roles of endogenous and exogenous galectin-1 in the control of testicular immunopathology.Linking tumor hypoxia with VEGFR2 signaling and compensatory angiogenesis: Glycans make the differenceEndomucin inhibits VEGF-induced endothelial cell migration, growth, and morphogenesis by modulating VEGFR2 signaling.Immune-Mediated and Hypoxia-Regulated Programs: Accomplices in Resistance to Anti-angiogenic Therapies.The Role of Galectins in Cervical Cancer Biology and Progression.Extracellular galectins as controllers of cytokines in hematological cancer
P2860
Q26801724-BD679232-DFEC-41FE-A725-A10CB6B5CA9DQ28075523-3B2999CE-2599-4A6F-B475-90E812C84DD2Q33705268-62048CD2-2E57-490B-8FE2-47AB023D8481Q34258192-605C8949-CF94-405A-84D5-667AA335A131Q35602405-1978F193-6AF8-4FB5-912B-0587D76A4144Q35661292-ED578F10-65DD-4977-BF70-D8BD569AA4CEQ36414261-8626278E-0686-4229-9040-14BD0D20DAFAQ37685683-8F101F88-054E-4B9D-966E-CAD91BC6094DQ38174863-E2E7173E-C2FE-4CF2-82B4-936CA683D18FQ38214807-E2629384-6EBA-4EC4-AE5F-820356D0EBCCQ38220163-71D4AC98-0A61-4497-A061-B86B8B259052Q38221079-E43DC9E5-558C-4105-B7BB-47BCC3ED9C64Q38269046-A43A66F6-26B8-4347-B167-0A0E287D79CBQ38269050-E42F547E-520C-49EC-A1CA-5032FDF2C15BQ40294860-A4A5A45F-ADD2-46C9-BB62-D91797AB202AQ42407157-56420C46-631D-4979-B57A-2A25A5210AE3Q42776209-416F9EB3-3D6B-4022-A4E9-D6C7F1C57E72Q49343847-3520A48D-A6CA-4448-B4B4-BF1B4AE6F25DQ53743967-356667D4-21FA-4285-8FDA-B8CB7EC0B418Q55152503-7A62C0F8-1D38-4AEC-ACAD-CD42846F8EBEQ58803547-8DA63C95-E7BD-40A2-A08E-47FDA1DA3D34
P2860
Vascular galectins: regulators of tumor progression and targets for cancer therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Vascular galectins: regulators of tumor progression and targets for cancer therapy.
@en
type
label
Vascular galectins: regulators of tumor progression and targets for cancer therapy.
@en
prefLabel
Vascular galectins: regulators of tumor progression and targets for cancer therapy.
@en
P1476
Vascular galectins: regulators of tumor progression and targets for cancer therapy
@en
P2093
Arjan W Griffioen
Gabriel A Rabinovich
P304
P356
10.1016/J.CYTOGFR.2013.07.003
P577
2013-08-12T00:00:00Z